<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5</volume><submitter>Mi Z</submitter><pubmed_abstract>Human BST-2 inhibits HIV-1 replication by tethering nascent virions to the cell surface. HIV-1 codes Vpu that counteracts BST-2 by down-regulating this restriction factor from the cell surface. This important function makes Vpu a potential therapeutic target. Yet, no agents have been reported to block Vpu from antagonizing BST-2. In this study, we report a small molecule compound IMB-LA that abrogates the function of Vpu and thereby strongly suppresses HIV-1 replication by sensitizing the virus to BST-2 restriction. Further studies revealed that IMB-LA specifically inhibits Vpu-mediated degradation of BST-2 and restores the expression of BST-2 at the cell surface. Although IMB-LA does not prevent Vpu from interacting with BST-2 or β-TrCP2-containing ubiquitin E3 ligase, sorting of BST-2 in</pubmed_abstract><journal>Scientific reports</journal><pagination>18499</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4680884</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.</pubmed_title><pmcid>PMC4680884</pmcid><pubmed_authors>Shan G</pubmed_authors><pubmed_authors>Cen S</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Ding J</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Yu H</pubmed_authors><pubmed_authors>Liang C</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Mi Z</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Wei T</pubmed_authors><pubmed_authors>Guo F</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.</name><description>Human BST-2 inhibits HIV-1 replication by tethering nascent virions to the cell surface. HIV-1 codes Vpu that counteracts BST-2 by down-regulating this restriction factor from the cell surface. This important function makes Vpu a potential therapeutic target. Yet, no agents have been reported to block Vpu from antagonizing BST-2. In this study, we report a small molecule compound IMB-LA that abrogates the function of Vpu and thereby strongly suppresses HIV-1 replication by sensitizing the virus to BST-2 restriction. Further studies revealed that IMB-LA specifically inhibits Vpu-mediated degradation of BST-2 and restores the expression of BST-2 at the cell surface. Although IMB-LA does not prevent Vpu from interacting with BST-2 or β-TrCP2-containing ubiquitin E3 ligase, sorting of BST-2 in</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Dec</publication><modification>2026-05-05T15:59:17.831Z</modification><creation>2019-03-27T02:05:14Z</creation></dates><accession>S-EPMC4680884</accession><cross_references><pubmed>26669976</pubmed><doi>10.1038/srep18499</doi></cross_references></HashMap>